1. Craighead JE, Abraham JL, Churg A, Green FH, Kleinerman J, Pratt PC, Seemayer TA, Vallyathan V, Weill H: The pathology of asbestos-associated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med. 1982, 106: 544-96.
2. Kayser K, Becker C, Seeberg N, Gabius HJ: Quantitation of asbestos and asbestos-like fibers in human lung tissue by hot and wet ashing, and the significance of their presence for survival of lung carcinoma and mesothelioma patients. Lung Cancer. 1999, 24: 89-98. 10.1016/S0169-5002(99)00035-5.
3. Kayser K, Seemann C, Andre S, Kugler C, Becker C, Dong X, Kaltner H, Gabius HJ: Association of concentration of asbestos and asbestos-like fibers with the patient's survival and the binding capacity of lung parenchyma to galectin-1 and natural alpha-galactoside- and alpha-mannoside-binding immunoglobulin G subfractions from human serum. Pathol Res Pract. 2000, 196: 81-87.
4. Valentin A: End of asbestos era. Haaretz, Weekend Magazine; 1989, 12.
5. Richter ED: Asbestos exposure in Israel: Findings, issues and needs. Israel J Med Sci. 1984, 20: 89-97.